secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-08-31T20:21:17+00:00
Accession:  0001178913-26-004360
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward CEO Mark Grant departs; interim CEO Josh Hexter and CFO Rami Aviram named
--------------------------------------------------------------------------------

- CEO Mark Grant steps down as President/CEO and director effective Aug 31, 2026; no cash severance, unvested equity forfeited.
- Grant to serve as Senior Advisor via consulting agreement through Sep 30, 2026 for $40,000 fee.
- Josh Hexter, Oramed's COO, appointed Interim CEO effective Sep 1, 2026; salary NIS 100,000/month + NIS 5,000 allowance.
- Rami Aviram appointed CFO effective Nov 1, 2026; salary NIS 70,000/month + NIS 5,000 allowance, succeeding Almog Adar.
- Interim CFO to cover gap between Adar's departure (Sep 30) and Aviram's start; Hexter reduces Oramed duties to ~5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326004360/0001178913-26-004360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326004360/a2636053.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-004360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer